Antares Pharma

Antares Pharma Current Liabilities

Delisted

The Current Liabilities of Antares Pharma (ATRS) as of Nov 2, 2026 is 83.11 M USD. In the previous year, Current Liabilities was 92.66 M USD — a change of -10.31% (lower).

Current Liabilities

83.11 MUSD

YoY

-10.31%

Last updated:

Current Liabilities of Antares Pharma is 2021 83.11 M USD. Current Liabilities of Antares Pharma was 2020 92.66 M USD. It decreases by -10.31% lower compared to the previous year.

The Antares Pharma Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2014
17.31 M USD
Jan 1, 2015
14.68 M USD
Jan 1, 2016
16.46 M USD
Jan 1, 2017
40.30 M USD
Jan 1, 2018
32.88 M USD
Jan 1, 2019
45.58 M USD
Jan 1, 2020
92.66 M USD
Jan 1, 2021
83.11 M USD
The Antares Pharma Current Liabilities history
YEARCurrent LiabilitiesYoY
83.11 MUSD-10.31%
92.66 MUSD+103.31%
45.58 MUSD+38.64%
32.88 MUSD-18.42%
40.30 MUSD+144.85%
16.46 MUSD+12.14%
14.68 MUSD-15.20%
17.31 MUSD+22.47%
14.13 MUSD+83.98%
7.68 MUSD+35.60%
5.66 MUSD+15.79%
4.89 MUSD+42.59%
3.43 MUSD-65.31%
9.89 MUSD+22.75%
8.06 MUSD+170.02%
2.98 MUSD+17.32%
2.54 MUSD+49.35%
1.70 MUSD-18.12%
2.08 MUSD-61.93%
5.46 MUSD+68.44%
3.24 MUSD-52.47%
6.82 MUSD+423.61%
1.30 MUSD+44.09%
904,424.00USD-0.46%
908,617.00USD+9.77%
827,765.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Antares Pharma Stock analysis

What does Antares Pharma do? The company Antares Pharma Inc was founded in 1979 in Minneapolis, USA. It has since become a successful company in the field of drug development and marketing. The company has been listed on the NASDAQ since 2006. Antares Pharma is a pharmaceutical company specializing in the development of injectable medications. Their business model is to develop innovative injectable products that meet the needs of patients and doctors, and are able to improve their therapy experience and increase adherence. The company specializes in three areas: self-injection systems, automatic devices, and pharmaceutical products. The innovation power behind Antares Pharma's development work is an important factor in their success, as well as their skills in market research and marketing. One of the company's main products is the VIBEX Pen, an automatic injection device that can be operated by patients themselves and filled with various therapeutics. The device provides an easy and painless way to administer medications. The company also produces the Makena auto-injector, which is used in pregnancy treatment. Another important product is the QuickShot auto-injector, a proprietary device used by patients to administer hormone preparations, immunomodulators, and various other common therapeutics. Due to its many years of experience and good reputation in the market, Antares Pharma has strong collaborative relationships with the pharmaceutical industry. The company's customers include reputable pharmaceutical companies such as Pfizer, Teva, Merck, and Novartis, who utilize the company's expertise to bring their own products to the market. Antares Pharma is headquartered in Ewing Township, New Jersey, USA. The company employs a variety of research and development experts who are constantly working to develop new medications and therapy approaches. It has strengthened its position as a major player in the pharmaceutical market and its goal remains to continue creating innovative solutions in the industry. Answer: Antares Pharma Inc. is a successful pharmaceutical company specializing in the development and marketing of injectable medications. They are known for their innovative products that improve therapy experiences and increase adherence. With a strong presence in the pharmaceutical market, Antares Pharma collaborates with renowned companies and continues to strive for innovative solutions. Antares Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Antares Pharma stock

Current Liabilities of Antares Pharma is 83.11 M USD in 2021.

Current Liabilities of Antares Pharma changed from 92.66 M USD to 83.11 M USD, representing a -10.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Antares Pharma since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Antares Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Antares Pharma

All Key Metrics — Antares Pharma